Patient Capital Management 13F, Q2 2026

Samantha McLemore · quarter ending 30 June 2026 · filed 13 August 2026 · SEC CIK 1854794

$3.01B
Filed US book
39
Positions
6.7%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed. The filing also lists 1 put and call lines, reported at the value of the underlying shares; they are not ownership and are not in these totals.

Largest positions, Q2 2026

The 25 largest of 39 positions. Weights are against the whole filed book. Changes are in shares held, against the Q1 2026 filing.

CompanyTickerValue% of bookvs Q1 2026
ROYALTY PHARMA PLC$201.79M6.7%unchanged
CITIGROUP INCC$196.43M6.5%unchanged
ALPHABET INCGOOGL$187.89M6.2%unchanged
UNITEDHEALTH GROUP INCUNH$181.95M6.0%unchanged
AMAZON COM INCAMZN$162.32M5.4%+4% shares
NVIDIA CORPORATIONNVDA$141.98M4.7%unchanged
CVS HEALTH CORPCVS$127.81M4.3%-9% shares
NORWEGIAN CRUISE LINE HLDGS$127.29M4.2%+5% shares
QXO INCQXO$123.32M4.1%+5% shares
ENERGY TRANSFER L PET$116.26M3.9%unchanged
PEOPLE INCPPLI$111.96M3.7%-10% shares
PRECIGEN INCPGEN$108.51M3.6%+7% shares
UNITED AIRLS HLDGS INCUAL$99.48M3.3%unchanged
CROCS INCCROX$96.44M3.2%-5% shares
META PLATFORMS INCMETA$96.20M3.2%unchanged
CHIME FINL INCCHYM$83.61M2.8%+42% shares
ADOBE INCADBE$74.04M2.5%+22% shares
SEADRILL LTD$73.88M2.5%-9% shares
GLOBAL PMTS INCGPN$68.37M2.3%new
COINBASE GLOBAL INCCOIN$67.54M2.2%+7% shares
FIDELITY WISE ORIGIN BITCOINFBTC$62.16M2.1%+244% shares
BIOGEN INCBIIB$61.30M2.0%-25% shares
ILLUMINA INCILMN$60.72M2.0%-37% shares
GENERAL MTRS COGM$48.68M1.6%-15% shares
UBS GROUP AG$47.27M1.6%-23% shares

What changed since Q1 2026

Against the Q1 2026 filing, Patient Capital Management opened 2 new positions, added to 9, trimmed 14, left 14 unchanged and exited 1. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

  • GPN$68.37M
  • GENIUS SPORTS LIMITED$4.93M

Exited

Added to

  • AMZN+4%$162.32M
  • NORWEGIAN CRUISE LINE HLDGS+5%$127.29M
  • QXO+5%$123.32M
  • PGEN+7%$108.51M
  • CHYM+42%$83.61M
  • ADBE+22%$74.04M
  • COIN+7%$67.54M
  • FBTC+244%$62.16M

and 1 more

Trimmed

  • CVS-9%$127.81M
  • PPLI-10%$111.96M
  • CROX-5%$96.44M
  • SEADRILL LTD-9%$73.88M
  • BIIB-25%$61.30M
  • ILMN-37%$60.72M
  • GM-15%$48.68M
  • UBS GROUP AG-23%$47.27M

and 6 more

Other quarters

Source: SEC Form 13F-HR, accession 0001854794-26-000005, filed by Patient Capital Management, LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.